Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitisPaul Chervinsky, Howard Fox, S. Hedgecock et al.|Annals of Allergy Asthma & Immunology|2003Cited by 214
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.Anjuli Nayak, Niroo Gupta, Thomas B. Casale et al.|PubMed|2004Cited by 45